Advertisement

Index by author

July 01, 1982; Volume 222,Issue 1

A

  1. Abe, Y

    1. Hypotensive action of angiotensin I converting enzyme inhibitor (SQ 14,225) in nephrectomized dogs.
      K Miura, Y Abe and K Yamamoto
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 246-250;

  2. Abraham, D J

    1. Long-term central cholinergic hypofunction induced in mice by ethylcholine aziridinium ion (AF64A) in vivo.
      A Fisher, C R Mantione, D J Abraham and I Hanin
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 140-145;

  3. Akera, T

    1. Inotropic effects of vanadate in isolated rat and guinea-pig heart under conditions which modify calcium pools involved in contractile activation.
      K Takeda, K Temma and T Akera
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 132-139;

  4. Alderdice, M T

    1. Primidone but not phenylethylmalonamide, a major metabolite, increases nerve-evoked transmitter release at the frog neuromuscular junction.
      P A Talbot and M T Alderdice
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 87-93;

B

  1. Best, K L

    1. A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain.
      D T Wong, P G Threlkeld, K L Best and F P Bymaster
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 61-65;

  2. Blaine, E H

    1. An orally active prostaglandin analog with renal vasodilatory activity in the dog.
      E H Blaine, H F Russo, T W Schorn and C Snyder
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 152-158;

  3. Block, E M

    1. Corneal lesions induced by antidepressants: a selective effect upon young Fischer 344 rats.
      P F Vonvoigtlander, G J Kolaja and E M Block
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 282-286;

  4. Brady, L S

    1. Analgesic effects of intraventricular morphine and enkephalins in nondependent and morphine-dependent rats.
      L S Brady and S G Holtzman
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 190-197;

  5. Bymaster, F P

    1. A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain.
      D T Wong, P G Threlkeld, K L Best and F P Bymaster
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 61-65;

C

  1. Caillé, G

    1. Nonrenal clearance of furosemide as a cause of diuretic response variability in the rat.
      C Lambert, G Caillé and P du Souich
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 232-236;

  2. Carbon, C

    1. Vancomycin in rabbits: pharmacokinetics, extravascular diffusion, renal excretion and interactions with furosemide.
      Y Nivoche, A Contrepois, A C Cremieux and C Carbon
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 237-240;

  3. Caturay, E M

    1. Studies on the structural prerequisites for the activation of the beta-endorphin receptor on the rat vas deferens.
      J P Huidobro-Toro, E M Caturay, N Ling, N M Lee, H H Loh and E L Way
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 262-269;

  4. Chan, K K

    1. Metabolite kinetics: formation of acetaminophen from deuterated and nondeuterated phenacetin and acetanilide on acetaminophen sulfation kinetics in the perfused rat liver preparation.
      K S Pang, L Waller, M G Horning and K K Chan
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 14-19;

  5. Chandra, A

    1. A norepinephrine-cyclic AMP link in the hypothalamic pathways which mediate fever induced by endotoxin and prostaglandin E2 in the rat.
      M T Lin, J J Wu, A Chandra and B L Tsay
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 251-257;

  6. Chen, F C

    1. Adenylate cyclase and beta adrenergic receptor development in the mouse heart.
      F C Chen, H I Yamamura and W R Roeske
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 7-13;

  7. Cicero, T J

    1. Role of testosterone in ethanol- and morphine-induced increases in the alcohol dehydrogenase-dependent metabolism of ethanol in the male rat.
      T J Cicero, K S Newman, P F Schmoeker and E R Meyer
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 20-28;

  8. Claeys, M

    1. Endothelium-dependent inhibitory effects of acetylcholine, adenosine triphosphate, thrombin and arachidonic acid in the canine femoral artery.
      J G De Mey, M Claeys and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 166-173;

  9. Clementi, W A

    1. Endogenous generation of hydralazine from labile hydralazine hydrazones.
      W A Clementi, J L McNay, T Talseth, K D Haegele, T M Ludden and G E Musgrave
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 159-165;

  10. Clohisy, D R

    1. Effect of quinidine on the renal clearance of digoxin in the presence of low and high serum digoxin concentrations.
      D R Clohisy, A P Quintanilla and T P Gibson
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 49-51;

  11. Contrepois, A

    1. Vancomycin in rabbits: pharmacokinetics, extravascular diffusion, renal excretion and interactions with furosemide.
      Y Nivoche, A Contrepois, A C Cremieux and C Carbon
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 237-240;

  12. Cook, M A

    1. The influence of glucosidic conformation and charge distribution on activity of adenine nucleosides as presynaptic inhibitors of acetylcholine release.
      M L Paul, D L Miles and M A Cook
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 241-245;

  13. Cowan, A

    1. The affinity of morphine for its pharmacologic receptor in vivo.
      R J Tallarida and A Cowan
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 198-201;

  14. Cremieux, A C

    1. Vancomycin in rabbits: pharmacokinetics, extravascular diffusion, renal excretion and interactions with furosemide.
      Y Nivoche, A Contrepois, A C Cremieux and C Carbon
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 237-240;

D

  1. Degregorio, C M

    1. Self-administration of the endogenous trace amines beta-phenylethylamine, N-methyl phenylethylamine and phenylethanolamine in dogs.
      H E Shannon and C M Degregorio
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 52-60;

  2. De Mey, J G

    1. Endothelium-dependent inhibitory effects of acetylcholine, adenosine triphosphate, thrombin and arachidonic acid in the canine femoral artery.
      J G De Mey, M Claeys and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 166-173;

  3. Dunnette, J H

    1. Pharmacogenetics of human thiopurine methyltransferase: kidney-erythrocyte correlation and immunotitration studies.
      L C Woodson, J H Dunnette and R M Weinshilboum
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 174-181;

  4. du Souich, P

    1. Nonrenal clearance of furosemide as a cause of diuretic response variability in the rat.
      C Lambert, G Caillé and P du Souich
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 232-236;

F

  1. Fisher, A

    1. Long-term central cholinergic hypofunction induced in mice by ethylcholine aziridinium ion (AF64A) in vivo.
      A Fisher, C R Mantione, D J Abraham and I Hanin
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 140-145;

  2. Foltin, R W

    1. Behavioral tolerance and cross-tolerance to dl-cathinone and d-amphetamine in rats.
      R W Foltin and C R Schuster
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 126-131;

G

  1. Gaffney, T E

    1. Nicotinic-like effects and tissue disposition of isopropylamine.
      P J Privitera, T Walle and T E Gaffney
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 116-121;

  2. García-Sáinz, J A

    1. Correlation between phosphatidylinositol labeling and contraction in rabbit aorta: effect of alpha-1 adrenergic activation.
      R Villalobos-Molina, M Uc, E Hong and J A García-Sáinz
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 258-261;

  3. Gibson, T P

    1. Effect of quinidine on the renal clearance of digoxin in the presence of low and high serum digoxin concentrations.
      D R Clohisy, A P Quintanilla and T P Gibson
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 49-51;

  4. Gleason, J G

    1. In vitro and in vivo mechanisms of leukotriene-mediated bronchoconstriction in the guinea pig.
      B M Weichman, R M Muccitelli, R R Osborn, D A Holden, J G Gleason and M A Wasserman
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 202-208;

  5. Goldman, S

    1. Effects of verapamil on positive inotropic stimulation in the left atrium and ventricle of conscious dogs.
      S Goldman, M Olajos and E Morkin
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 270-275;

H

  1. Haegele, K D

    1. Endogenous generation of hydralazine from labile hydralazine hydrazones.
      W A Clementi, J L McNay, T Talseth, K D Haegele, T M Ludden and G E Musgrave
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 159-165;

  2. Hanin, I

    1. Long-term central cholinergic hypofunction induced in mice by ethylcholine aziridinium ion (AF64A) in vivo.
      A Fisher, C R Mantione, D J Abraham and I Hanin
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 140-145;

  3. Hauser, G

    1. Phospholipid metabolism changes in rat tissues in vitro after injections of propranolol.
      A S Pappu and G Hauser
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 109-115;

  4. Hoffman, P L

    1. Alterations in opiate receptor function after chronic ethanol exposure.
      P L Hoffman, S Urwyler and B Tabakoff
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 182-189;

  5. Holden, D A

    1. In vitro and in vivo mechanisms of leukotriene-mediated bronchoconstriction in the guinea pig.
      B M Weichman, R M Muccitelli, R R Osborn, D A Holden, J G Gleason and M A Wasserman
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 202-208;

  6. Holtzman, S G

    1. Analgesic effects of intraventricular morphine and enkephalins in nondependent and morphine-dependent rats.
      L S Brady and S G Holtzman
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 190-197;

  7. Hong, E

    1. Correlation between phosphatidylinositol labeling and contraction in rabbit aorta: effect of alpha-1 adrenergic activation.
      R Villalobos-Molina, M Uc, E Hong and J A García-Sáinz
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 258-261;

  8. Horita, A

    1. Thyrotropin releasing hormone: centrally mediated effects on gastrointestinal motor activity.
      T R LaHann and A Horita
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 66-70;

  9. Horning, M G

    1. Metabolite kinetics: formation of acetaminophen from deuterated and nondeuterated phenacetin and acetanilide on acetaminophen sulfation kinetics in the perfused rat liver preparation.
      K S Pang, L Waller, M G Horning and K K Chan
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 14-19;

  10. Huidobro-Toro, J P

    1. Studies on the structural prerequisites for the activation of the beta-endorphin receptor on the rat vas deferens.
      J P Huidobro-Toro, E M Caturay, N Ling, N M Lee, H H Loh and E L Way
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 262-269;
    2. Kappa opioid properties of dynorphin and its peptide fragments on the guinea-pig Ileum.
      K Yoshimura, J P Huidobro-Toro, N M Lee, H H Löh and E L Way
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 71-79;

  11. Humphrey, S J

    1. Involvement of serotonin in the central regulation of blood pressure: evidence for a facilitating effect on sympathetic nerve activity.
      R B McCall and S J Humphrey
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 94-102;

K

  1. Kalivas, P W

    1. Histamine-induced arousal in the conscious and pentobarbital-pretreated rat.
      P W Kalivas
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 37-42;

  2. Kalkman, H O

    1. Characterization of the antihypertensive properties of ketanserin (R 41 468) in rats.
      H O Kalkman, P B Timmermans and P A Van Zwieten
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 227-231;

  3. Kerr, L M

    1. Effect of the calcium antagonists bepridil (CERM-1978) and verapamil on Ca++-dependent slow action potentials in frog skeletal muscle.
      L M Kerr and N Sperelakis
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 80-86;

  4. Kolaja, G J

    1. Corneal lesions induced by antidepressants: a selective effect upon young Fischer 344 rats.
      P F Vonvoigtlander, G J Kolaja and E M Block
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 282-286;

L

  1. LaHann, T R

    1. Thyrotropin releasing hormone: centrally mediated effects on gastrointestinal motor activity.
      T R LaHann and A Horita
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 66-70;

  2. Lambert, C

    1. Nonrenal clearance of furosemide as a cause of diuretic response variability in the rat.
      C Lambert, G Caillé and P du Souich
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 232-236;

  3. Langer, S Z

    1. Citalopram antagonizes the stimulation by lysergic acid diethylamide of presynaptic inhibitory serotonin autoreceptors in the rat hypothalamus.
      S Z Langer and C Moret
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 220-226;

  4. Lapollo, J

    1. Cocaine potentiates ketamine-induced loss of the righting reflex and sleeping time in mice. Role of catecholamines.
      C Vanderwende, M T Spoerlein and J Lapollo
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 122-125;

  5. Le Breton, G C

    1. Thromboxane A2/prostaglandin H2 directly stimulates platelet shape change independent of secreted ADP.
      L V Parise, D L Venton and G C Le Breton
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 276-281;

  6. Lee, N M

    1. Studies on the structural prerequisites for the activation of the beta-endorphin receptor on the rat vas deferens.
      J P Huidobro-Toro, E M Caturay, N Ling, N M Lee, H H Loh and E L Way
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 262-269;
    2. Kappa opioid properties of dynorphin and its peptide fragments on the guinea-pig Ileum.
      K Yoshimura, J P Huidobro-Toro, N M Lee, H H Löh and E L Way
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 71-79;

  7. Lin, M T

    1. A norepinephrine-cyclic AMP link in the hypothalamic pathways which mediate fever induced by endotoxin and prostaglandin E2 in the rat.
      M T Lin, J J Wu, A Chandra and B L Tsay
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 251-257;

  8. Ling, N

    1. Studies on the structural prerequisites for the activation of the beta-endorphin receptor on the rat vas deferens.
      J P Huidobro-Toro, E M Caturay, N Ling, N M Lee, H H Loh and E L Way
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 262-269;

  9. Loh, H H

    1. Studies on the structural prerequisites for the activation of the beta-endorphin receptor on the rat vas deferens.
      J P Huidobro-Toro, E M Caturay, N Ling, N M Lee, H H Loh and E L Way
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 262-269;

  10. Löh, H H

    1. Kappa opioid properties of dynorphin and its peptide fragments on the guinea-pig Ileum.
      K Yoshimura, J P Huidobro-Toro, N M Lee, H H Löh and E L Way
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 71-79;

  11. Ludden, T M

    1. Endogenous generation of hydralazine from labile hydralazine hydrazones.
      W A Clementi, J L McNay, T Talseth, K D Haegele, T M Ludden and G E Musgrave
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 159-165;

M

  1. Mantione, C R

    1. Long-term central cholinergic hypofunction induced in mice by ethylcholine aziridinium ion (AF64A) in vivo.
      A Fisher, C R Mantione, D J Abraham and I Hanin
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 140-145;

  2. McCall, R B

    1. Involvement of serotonin in the central regulation of blood pressure: evidence for a facilitating effect on sympathetic nerve activity.
      R B McCall and S J Humphrey
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 94-102;

  3. McKearney, J W

    1. Effects of tricyclic antidepressant and anticholinergic drugs on fixed-interval responding in the squirrel monkey.
      J W McKearney
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 215-219;

  4. McNay, J L

    1. Endogenous generation of hydralazine from labile hydralazine hydrazones.
      W A Clementi, J L McNay, T Talseth, K D Haegele, T M Ludden and G E Musgrave
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 159-165;

  5. Meyer, E R

    1. Role of testosterone in ethanol- and morphine-induced increases in the alcohol dehydrogenase-dependent metabolism of ethanol in the male rat.
      T J Cicero, K S Newman, P F Schmoeker and E R Meyer
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 20-28;

  6. Miles, D L

    1. The influence of glucosidic conformation and charge distribution on activity of adenine nucleosides as presynaptic inhibitors of acetylcholine release.
      M L Paul, D L Miles and M A Cook
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 241-245;

  7. Miura, K

    1. Hypotensive action of angiotensin I converting enzyme inhibitor (SQ 14,225) in nephrectomized dogs.
      K Miura, Y Abe and K Yamamoto
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 246-250;

  8. Moret, C

    1. Citalopram antagonizes the stimulation by lysergic acid diethylamide of presynaptic inhibitory serotonin autoreceptors in the rat hypothalamus.
      S Z Langer and C Moret
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 220-226;

  9. Morkin, E

    1. Effects of verapamil on positive inotropic stimulation in the left atrium and ventricle of conscious dogs.
      S Goldman, M Olajos and E Morkin
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 270-275;

  10. Muccitelli, R M

    1. In vitro and in vivo mechanisms of leukotriene-mediated bronchoconstriction in the guinea pig.
      B M Weichman, R M Muccitelli, R R Osborn, D A Holden, J G Gleason and M A Wasserman
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 202-208;

  11. Mueller, G P

    1. Adrenergic control of immunoreactive beta-endorphin release from the pituitary of the rat: in vitro and in vivo studies.
      D J Pettibone and G P Mueller
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 103-108;

  12. Musgrave, G E

    1. Endogenous generation of hydralazine from labile hydralazine hydrazones.
      W A Clementi, J L McNay, T Talseth, K D Haegele, T M Ludden and G E Musgrave
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 159-165;

N

  1. Newman, K S

    1. Role of testosterone in ethanol- and morphine-induced increases in the alcohol dehydrogenase-dependent metabolism of ethanol in the male rat.
      T J Cicero, K S Newman, P F Schmoeker and E R Meyer
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 20-28;

  2. Nivoche, Y

    1. Vancomycin in rabbits: pharmacokinetics, extravascular diffusion, renal excretion and interactions with furosemide.
      Y Nivoche, A Contrepois, A C Cremieux and C Carbon
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 237-240;

O

  1. Olajos, M

    1. Effects of verapamil on positive inotropic stimulation in the left atrium and ventricle of conscious dogs.
      S Goldman, M Olajos and E Morkin
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 270-275;

  2. Osborn, R R

    1. In vitro and in vivo mechanisms of leukotriene-mediated bronchoconstriction in the guinea pig.
      B M Weichman, R M Muccitelli, R R Osborn, D A Holden, J G Gleason and M A Wasserman
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 202-208;

P

  1. Pang, K S

    1. Metabolite kinetics: formation of acetaminophen from deuterated and nondeuterated phenacetin and acetanilide on acetaminophen sulfation kinetics in the perfused rat liver preparation.
      K S Pang, L Waller, M G Horning and K K Chan
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 14-19;

  2. Pappu, A S

    1. Phospholipid metabolism changes in rat tissues in vitro after injections of propranolol.
      A S Pappu and G Hauser
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 109-115;

  3. Parise, L V

    1. Thromboxane A2/prostaglandin H2 directly stimulates platelet shape change independent of secreted ADP.
      L V Parise, D L Venton and G C Le Breton
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 276-281;

  4. Paul, M L

    1. The influence of glucosidic conformation and charge distribution on activity of adenine nucleosides as presynaptic inhibitors of acetylcholine release.
      M L Paul, D L Miles and M A Cook
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 241-245;

  5. Pettibone, D J

    1. Adrenergic control of immunoreactive beta-endorphin release from the pituitary of the rat: in vitro and in vivo studies.
      D J Pettibone and G P Mueller
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 103-108;

  6. Privitera, P J

    1. Nicotinic-like effects and tissue disposition of isopropylamine.
      P J Privitera, T Walle and T E Gaffney
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 116-121;

Q

  1. Quintanilla, A P

    1. Effect of quinidine on the renal clearance of digoxin in the presence of low and high serum digoxin concentrations.
      D R Clohisy, A P Quintanilla and T P Gibson
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 49-51;

R

  1. Roeske, W R

    1. Adenylate cyclase and beta adrenergic receptor development in the mouse heart.
      F C Chen, H I Yamamura and W R Roeske
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 7-13;

  2. Ruffolo, R R

    1. Receptor interactions of imidazolines. IX. Cirazoline is an alpha-1 adrenergic agonist and an alpha-2 adrenergic antagonist.
      R R Ruffolo and J E Waddell
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 29-36;

  3. Russo, H F

    1. An orally active prostaglandin analog with renal vasodilatory activity in the dog.
      E H Blaine, H F Russo, T W Schorn and C Snyder
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 152-158;

S

  1. Schanberg, S

    1. Involvement of alpha noradrenergic receptors in mediation of brain polyphosphoinositides metabolism in vivo.
      J Soukup and S Schanberg
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 209-214;

  2. Schmoeker, P F

    1. Role of testosterone in ethanol- and morphine-induced increases in the alcohol dehydrogenase-dependent metabolism of ethanol in the male rat.
      T J Cicero, K S Newman, P F Schmoeker and E R Meyer
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 20-28;

  3. Schorn, T W

    1. An orally active prostaglandin analog with renal vasodilatory activity in the dog.
      E H Blaine, H F Russo, T W Schorn and C Snyder
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 152-158;

  4. Schuster, C R

    1. Behavioral tolerance and cross-tolerance to dl-cathinone and d-amphetamine in rats.
      R W Foltin and C R Schuster
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 126-131;

  5. Shannon, H E

    1. Pharmacological analysis of the phencyclidine-like discriminative stimulus properties of narcotic derivatives in rats.
      H E Shannon
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 146-151;
    2. Self-administration of the endogenous trace amines beta-phenylethylamine, N-methyl phenylethylamine and phenylethanolamine in dogs.
      H E Shannon and C M Degregorio
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 52-60;

  6. Simpson, L L

    1. The interaction between aminoquinolines and presynaptically acting neurotoxins.
      L L Simpson
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 43-48;

  7. Snyder, C

    1. An orally active prostaglandin analog with renal vasodilatory activity in the dog.
      E H Blaine, H F Russo, T W Schorn and C Snyder
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 152-158;

  8. Soukup, J

    1. Involvement of alpha noradrenergic receptors in mediation of brain polyphosphoinositides metabolism in vivo.
      J Soukup and S Schanberg
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 209-214;

  9. Spector, R

    1. Pharmacokinetics and metabolism of cytosine arabinoside in the central nervous system.
      R Spector
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 1-6;

  10. Sperelakis, N

    1. Effect of the calcium antagonists bepridil (CERM-1978) and verapamil on Ca++-dependent slow action potentials in frog skeletal muscle.
      L M Kerr and N Sperelakis
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 80-86;

  11. Spoerlein, M T

    1. Cocaine potentiates ketamine-induced loss of the righting reflex and sleeping time in mice. Role of catecholamines.
      C Vanderwende, M T Spoerlein and J Lapollo
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 122-125;

T

  1. Tabakoff, B

    1. Alterations in opiate receptor function after chronic ethanol exposure.
      P L Hoffman, S Urwyler and B Tabakoff
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 182-189;

  2. Takeda, K

    1. Inotropic effects of vanadate in isolated rat and guinea-pig heart under conditions which modify calcium pools involved in contractile activation.
      K Takeda, K Temma and T Akera
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 132-139;

  3. Talbot, P A

    1. Primidone but not phenylethylmalonamide, a major metabolite, increases nerve-evoked transmitter release at the frog neuromuscular junction.
      P A Talbot and M T Alderdice
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 87-93;

  4. Tallarida, R J

    1. The affinity of morphine for its pharmacologic receptor in vivo.
      R J Tallarida and A Cowan
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 198-201;

  5. Talseth, T

    1. Endogenous generation of hydralazine from labile hydralazine hydrazones.
      W A Clementi, J L McNay, T Talseth, K D Haegele, T M Ludden and G E Musgrave
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 159-165;

  6. Temma, K

    1. Inotropic effects of vanadate in isolated rat and guinea-pig heart under conditions which modify calcium pools involved in contractile activation.
      K Takeda, K Temma and T Akera
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 132-139;

  7. Threlkeld, P G

    1. A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain.
      D T Wong, P G Threlkeld, K L Best and F P Bymaster
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 61-65;

  8. Timmermans, P B

    1. Characterization of the antihypertensive properties of ketanserin (R 41 468) in rats.
      H O Kalkman, P B Timmermans and P A Van Zwieten
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 227-231;

  9. Tsay, B L

    1. A norepinephrine-cyclic AMP link in the hypothalamic pathways which mediate fever induced by endotoxin and prostaglandin E2 in the rat.
      M T Lin, J J Wu, A Chandra and B L Tsay
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 251-257;

U

  1. Uc, M

    1. Correlation between phosphatidylinositol labeling and contraction in rabbit aorta: effect of alpha-1 adrenergic activation.
      R Villalobos-Molina, M Uc, E Hong and J A García-Sáinz
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 258-261;

  2. Urwyler, S

    1. Alterations in opiate receptor function after chronic ethanol exposure.
      P L Hoffman, S Urwyler and B Tabakoff
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 182-189;

V

  1. Vanderwende, C

    1. Cocaine potentiates ketamine-induced loss of the righting reflex and sleeping time in mice. Role of catecholamines.
      C Vanderwende, M T Spoerlein and J Lapollo
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 122-125;

  2. Vanhoutte, P M

    1. Endothelium-dependent inhibitory effects of acetylcholine, adenosine triphosphate, thrombin and arachidonic acid in the canine femoral artery.
      J G De Mey, M Claeys and P M Vanhoutte
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 166-173;

  3. Van Zwieten, P A

    1. Characterization of the antihypertensive properties of ketanserin (R 41 468) in rats.
      H O Kalkman, P B Timmermans and P A Van Zwieten
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 227-231;

  4. Venton, D L

    1. Thromboxane A2/prostaglandin H2 directly stimulates platelet shape change independent of secreted ADP.
      L V Parise, D L Venton and G C Le Breton
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 276-281;

  5. Villalobos-Molina, R

    1. Correlation between phosphatidylinositol labeling and contraction in rabbit aorta: effect of alpha-1 adrenergic activation.
      R Villalobos-Molina, M Uc, E Hong and J A García-Sáinz
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 258-261;

  6. Vonvoigtlander, P F

    1. Corneal lesions induced by antidepressants: a selective effect upon young Fischer 344 rats.
      P F Vonvoigtlander, G J Kolaja and E M Block
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 282-286;

W

  1. Waddell, J E

    1. Receptor interactions of imidazolines. IX. Cirazoline is an alpha-1 adrenergic agonist and an alpha-2 adrenergic antagonist.
      R R Ruffolo and J E Waddell
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 29-36;

  2. Walle, T

    1. Nicotinic-like effects and tissue disposition of isopropylamine.
      P J Privitera, T Walle and T E Gaffney
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 116-121;

  3. Waller, L

    1. Metabolite kinetics: formation of acetaminophen from deuterated and nondeuterated phenacetin and acetanilide on acetaminophen sulfation kinetics in the perfused rat liver preparation.
      K S Pang, L Waller, M G Horning and K K Chan
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 14-19;

  4. Wasserman, M A

    1. In vitro and in vivo mechanisms of leukotriene-mediated bronchoconstriction in the guinea pig.
      B M Weichman, R M Muccitelli, R R Osborn, D A Holden, J G Gleason and M A Wasserman
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 202-208;

  5. Way, E L

    1. Studies on the structural prerequisites for the activation of the beta-endorphin receptor on the rat vas deferens.
      J P Huidobro-Toro, E M Caturay, N Ling, N M Lee, H H Loh and E L Way
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 262-269;
    2. Kappa opioid properties of dynorphin and its peptide fragments on the guinea-pig Ileum.
      K Yoshimura, J P Huidobro-Toro, N M Lee, H H Löh and E L Way
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 71-79;

  6. Weichman, B M

    1. In vitro and in vivo mechanisms of leukotriene-mediated bronchoconstriction in the guinea pig.
      B M Weichman, R M Muccitelli, R R Osborn, D A Holden, J G Gleason and M A Wasserman
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 202-208;

  7. Weinshilboum, R M

    1. Pharmacogenetics of human thiopurine methyltransferase: kidney-erythrocyte correlation and immunotitration studies.
      L C Woodson, J H Dunnette and R M Weinshilboum
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 174-181;

  8. Wong, D T

    1. A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain.
      D T Wong, P G Threlkeld, K L Best and F P Bymaster
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 61-65;

  9. Woodson, L C

    1. Pharmacogenetics of human thiopurine methyltransferase: kidney-erythrocyte correlation and immunotitration studies.
      L C Woodson, J H Dunnette and R M Weinshilboum
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 174-181;

  10. Wu, J J

    1. A norepinephrine-cyclic AMP link in the hypothalamic pathways which mediate fever induced by endotoxin and prostaglandin E2 in the rat.
      M T Lin, J J Wu, A Chandra and B L Tsay
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 251-257;

Y

  1. Yamamoto, K

    1. Hypotensive action of angiotensin I converting enzyme inhibitor (SQ 14,225) in nephrectomized dogs.
      K Miura, Y Abe and K Yamamoto
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 246-250;

  2. Yamamura, H I

    1. Adenylate cyclase and beta adrenergic receptor development in the mouse heart.
      F C Chen, H I Yamamura and W R Roeske
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 7-13;

  3. Yoshimura, K

    1. Kappa opioid properties of dynorphin and its peptide fragments on the guinea-pig Ileum.
      K Yoshimura, J P Huidobro-Toro, N M Lee, H H Löh and E L Way
      Journal of Pharmacology and Experimental Therapeutics July 1982, 222 (1) 71-79;
Back to top

In this issue